Testing effectiveness (Phase 2)Ended earlyNCT01061580What this trial is testingBMAC Enhanced Coronary Artery Bypass Grafting (CABG)Who this might be right forCongestive Heart Failure Harvest Technologies 20
Testing effectiveness (Phase 2)UnknownNCT02709876What this trial is testingAutologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis PigmentosaWho this might be right forRetinitis Pigmentosa Stem Cells Arabia 50
Testing effectiveness (Phase 2)Study completedNCT02500550What this trial is testingSafety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical DonorWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome Kiadis Pharma 15
Not applicableLooking for participantsNCT05823376What this trial is testingAvatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure DiseaseWho this might be right forPlatelet Recovery After Umbilical Cord Blood Transplantation Anhui Provincial Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT00720850What this trial is testingLenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)Who this might be right forMyelodysplastic SyndromesAcute Myelogenous Leukemia Technische Universität Dresden 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262843What this trial is testingTotal Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+1 more City of Hope Medical Center 33
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Testing effectiveness (Phase 2)Ended earlyNCT00638820What this trial is testingReduced Intensity AlloTransplant For OsteopetrosisWho this might be right forOsteopetrosis Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT00750659What this trial is testingNilotinib Pre and Post Allogeneic Stem Cell TransplantationWho this might be right forChronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaStem Cell Transplantation Sheba Medical Center 24
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT00578942What this trial is testingAllo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using CampathWho this might be right forLymphomaMyelomaLeukemia+2 more David Rizzieri, MD 48
Very early researchUnknownNCT03248466What this trial is testingPRG Combined With Autologous BMMSCs for Treatment of Diabetic Foot UlcerWho this might be right forDiabetic Foot Ulcer Third Military Medical University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06529731What this trial is testingInterferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndromes Sawa Ito, MD 45
Early research (Phase 1)Study completedNCT01239862What this trial is testingSafety of Stem Cells Intrabronchial Instillation for SilicosisWho this might be right forChronic and Accelerated Silicosis Universidade Federal do Rio de Janeiro 5
Testing effectiveness (Phase 2)Study completedNCT02988466What this trial is testingReduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCTWho this might be right forHematologic Malignancies Masonic Cancer Center, University of Minnesota 78
Early research (Phase 1)Study completedNCT00891137What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Cellerant Therapeutics 30
Testing effectiveness (Phase 2)Ended earlyNCT01500161What this trial is testingPooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more Texas Oncology Cancer Center 1
Not applicableStudy completedNCT07551154What this trial is testingVirtual Surgical Planning of Mandibular Reconstruction Using Custom Made Plate and Split Rib Bundle Bone GrafWho this might be right forMandibular Injuries Alexandria University 30
Not applicableLooking for participantsNCT05537545What this trial is testingTiming of Soft Tissue Grafting Following Immediate Implant PlacementWho this might be right forBone Resorption University Ghent 40
Testing effectiveness (Phase 2)Study completedNCT00644241What this trial is testingEfficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes MellitusWho this might be right forType 2 Diabetes Mellitus Post Graduate Institute of Medical Education and Research, Chandigarh 10